{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T15:49:51Z","timestamp":1724428191612},"reference-count":0,"publisher":"Gavin Publishers","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomark Applic"],"DOI":"10.29011\/2576-9588.100030","type":"journal-article","created":{"date-parts":[[2020,3,4]],"date-time":"2020-03-04T05:18:38Z","timestamp":1583299118000},"source":"Crossref","is-referenced-by-count":1,"title":["Glymphatic Efficiency is a Critical Factor for Using Abnormal Tau in Peripheral Tissues as Biomarker for Alzheimer\u2019s Disease"],"prefix":"10.29011","volume":"2","member":"11549","published-online":{"date-parts":[[2018,12,28]]},"container-title":["Biomarkers and Applications"],"original-title":[],"deposited":{"date-parts":[[2020,3,4]],"date-time":"2020-03-04T05:18:39Z","timestamp":1583299119000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.gavinpublishers.com\/articles\/short-communication\/Biomarkers-and-Applications\/glymphatic-efficiency-is-a-critical-factor-for-using-abnormal-tau-in-peripheral-tissues-as-biomarker-for-alzheimers-disease"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,28]]},"references-count":0,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2018,12,28]]}},"URL":"https:\/\/doi.org\/10.29011\/2576-9588.100030","relation":{},"ISSN":["2576-9588"],"issn-type":[{"value":"2576-9588","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,28]]}}}